Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also known as FRAP-connected protein (FRP1)) has emerged like a promising approach for cancer treatment that exploits artificial lethal interactions with proteins involved in DNA damage maintenance, overcomes resistance to other therapies and boosts antitumour immunity. Ma... https://moshea196mkg0.ziblogs.com/profile